Responses
Clinical/translational cancer immunotherapy
Original research
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
Compose a Response to This Article
Other responses
No responses have been published for this article.
